ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
0,00%
Bitcoin
69 368,42
0,05%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. TELA Bio Inc (TELA)

  7. TELA Bio Inc (TELA) Actualités

TELA

TELA Bio (TELA)

TELA Bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TELA
DateHeureSourceTitreSymboleSociété
06/06/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TELATELA Bio Inc
06/06/202422h55Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TELATELA Bio Inc
06/06/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TELATELA Bio Inc
04/06/202422h05GlobeNewswire Inc.TELA Bio Appoints Jeffrey Blizard to its Board of DirectorsNASDAQ:TELATELA Bio Inc
20/05/202422h03GlobeNewswire Inc.TELA Bio Appoints Greg Firestone as Chief Commercial OfficerNASDAQ:TELATELA Bio Inc
10/05/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TELATELA Bio Inc
10/05/202422h05GlobeNewswire Inc.TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TELATELA Bio Inc
09/05/202422h05GlobeNewswire Inc.TELA Bio Reports First Quarter 2024 Financial ResultsNASDAQ:TELATELA Bio Inc
25/04/202413h00GlobeNewswire Inc.TELA Bio to Announce First Quarter 2024 Financial ResultsNASDAQ:TELATELA Bio Inc
15/04/202413h00GlobeNewswire Inc.TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia ProceduresNASDAQ:TELATELA Bio Inc
08/04/202413h00GlobeNewswire Inc.TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon StrategyNASDAQ:TELATELA Bio Inc
21/03/202421h05GlobeNewswire Inc.TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial ResultsNASDAQ:TELATELA Bio Inc
21/03/202412h00GlobeNewswire Inc.TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia SurgeryNASDAQ:TELATELA Bio Inc
20/03/202412h00GlobeNewswire Inc.MIMEDX Expands Portfolio with Fibrillar Collagen Wound DressingNASDAQ:TELATELA Bio Inc
20/03/202412h00GlobeNewswire Inc.TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDXNASDAQ:TELATELA Bio Inc
29/02/202413h00GlobeNewswire Inc.TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:TELATELA Bio Inc
16/02/202422h05Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:TELATELA Bio Inc
14/02/202423h23Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TELATELA Bio Inc
05/12/202313h00GlobeNewswire Inc.TELA Bio to Take Part in Connecting the DotsNASDAQ:TELATELA Bio Inc
21/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TELATELA Bio Inc
16/11/202313h00GlobeNewswire Inc.TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare ConferenceNASDAQ:TELATELA Bio Inc
13/11/202322h44Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TELATELA Bio Inc
09/11/202322h05GlobeNewswire Inc.TELA Bio Reports Third Quarter 2023 Financial ResultsNASDAQ:TELATELA Bio Inc
26/10/202313h00GlobeNewswire Inc.TELA Bio to Announce Third Quarter 2023 Financial ResultsNASDAQ:TELATELA Bio Inc
18/09/202322h05GlobeNewswire Inc.TELA Bio to Participate in the Gilmartin Group Emerging Growth Company ShowcaseNASDAQ:TELATELA Bio Inc
16/08/202313h00GlobeNewswire Inc.TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive SurgeryNASDAQ:TELATELA Bio Inc
09/08/202322h03GlobeNewswire Inc.TELA Bio Reports Second Quarter 2023 Financial ResultsNASDAQ:TELATELA Bio Inc
26/07/202313h00GlobeNewswire Inc.TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:TELATELA Bio Inc
15/06/202313h00GlobeNewswire Inc.New Survey Finds Strong Consumer Preference for More Natural Hernia Repair OptionsNASDAQ:TELATELA Bio Inc
02/06/202322h39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TELATELA Bio Inc
 Showing the most relevant articles for your search:NASDAQ:TELA

Dernières Valeurs Consultées

BIT
S24968
SG ISSUER
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés